A roadmap to key pharmacologic principles in using antipsychotics.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Primary Care Companion to the Journal Clinical Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/pcc.v09n0607PMID 18185824PMCID PMC2139919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a Roadmap.

  2007influential reference
• Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

  2007cited by this paper
• Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

  2006cited by this paper
• Switching in the era of atypical antipsychotics. An updated review.

  2006cited by this paper
• Aripiprazole for schizophrenia

  2006cited by this paper
• Aripiprazole for schizophrenia Systematic review

  2006cited by this paper
• Guide to Psychiatric Drug Interactions

  2006influential reference
• The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation.

  2005cited by this paper
• Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations

  2005cited by this paper
• The American Psychiatric Association

  2005cited by this paper
• Second-Generation (Atypical) Antipsychotics and Metabolic Effects

  2005cited by this paper
• Modern antipsychotic drugs: a critical overview

  2005cited by this paper
• Practice guideline for the treatment of patients with schizophrenia, second edition.

  2004cited by this paper
• Outcomes of the peer‐taught 12‐week family‐to‐family education program for severe mental illness

  2004cited by this paper
• Classification of Neuropsychiatric Medications by Principal Mechanism of Action: A Meaningful Way to Anticipate Pharmacodynamically Mediated Drug Interactions (Part II)

  2004cited by this paper
• Consensus development conference on antipsychotic drugs and obesity and diabetes.

  2004cited by this paper
• Integrated Treatment of Co-Occurring Mental Illness and Addiction: Clinical Intervention, Program, and System Perspectives

  2004cited by this paper
• Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

  2003cited by this paper
• Classification of neuropsychiatric medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions.

  2003cited by this paper
• Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• In the News: Compiled from Agency for Healthcare Research and Quality Web Site

  2001cited by this paper
• Dopamine as a prolactin (PRL) inhibitor.

  2001cited by this paper
• Metabolic Drug Interactions

  2000influential reference
• Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence

  1998cited by this paper
• Practice guideline for the treatment of patients with schizophrenia

  1997cited by this paper
• Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats

  1996cited by this paper
• Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.

  1996cited by this paper
• Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

  1995influential reference
• Pharmacology of antidepressants--characteristics of the ideal drug.

  1994cited by this paper

• Patterns of Prescription of Psychotropic Medications and Their Adherence among Patients with Schizophrenia in Two Psychiatric Hospitals in Accra, Ghana: A Cross-Sectional Survey

  2018cites this paper
• Acute Effects of Music Therapy in Subjects With Psychosis During Inpatient Treatment

  2018cites this paper
• Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review

  2016cites this paper
• Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis

  2016cites this paper
• Gr upSM Pharmacogenetic and Epigenetic Mechanisms of Antipsychotic Drugs

  2016cites this paper
• Dental Health and the Type of Antipsychotic Treatment in Inpatients with Schizophrenia.

  2015cites this paper
• Reading group rehabilitation for patients with psychosis: a randomized controlled study.

  2015cites this paper
• The genetics of vascular incidents associated with second-generation antipsychotic administration

  2014cites this paper
• Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational Studies

  2014cites this paper
• Dietary energy intakes in children with mental health conditions treated with second‐generation antipsychotics (371.8)

  2014cites this paper
• IN-SILICO PROTEIN LIGAND INTERACTION STUDY OF TYPICAL ANTIPSYCHOTIC DRUGS AGAINST DOPAMINERGIC D2 RECEPTOR

  2013cites this paper
• Epigenetics of psychoactive drugs

  2012cites this paper
• Prilocaína a 3% associada à felipressina na anestesia peribulbar de gatos = Prilocaine 3% associated with felipressin peribulbar anesthesia in cats

  2011cites this paper
• Method Development and Validation of the Quantitation of 19 Antipsychotics Using Deuterated Internal Standards

  2011cites this paper